Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
03 2019
Historique:
received: 04 06 2018
accepted: 20 07 2018
pubmed: 16 8 2018
medline: 14 6 2019
entrez: 16 8 2018
Statut: ppublish

Résumé

Oligodendrogliomas are heterogeneous tumors in terms of imaging appearance, and a deeper understanding of the histopathological tumor characteristics in correlation to imaging parameters is needed. We used PET-to-MRI-to-histology co-registration with the aim of studying intra-tumoral Consecutive histological sections of four tumors covering the entire en bloc-removed tumor were immunostained with antibodies against IDH1-mutated protein (tumor cells), Ki67 (proliferating cells), and CD34 (blood vessels). Software was developed for anatomical landmarks-based co-registration of subsequent histological images, which were overlaid on corresponding MET PET scans and MRI perfusion maps. Regions of interest (ROIs) on PET were selected throughout the entire tumor volume, covering hot spot areas, areas adjacent to hot spots, and tumor borders with infiltrating zone. Tumor-to-normal tissue (T/N) ratios of MET uptake and mean relative cerebral blood volume (rCBV) were measured in the ROIs and protein expression of histological cell markers was quantified in corresponding regions. Statistical correlations were calculated between MET uptake, rCBV, and quantified protein expression. A total of 84 ROIs were selected in four oligodendrogliomas. A significant correlation (p < 0.05) between MET uptake and tumor cell density was demonstrated in all tumors separately. In two tumors, MET correlated with the density of proliferating cells and vessel cell density. There were no significant correlations between MET uptake and rCBV, and between rCBV and histological cell markers. The MET uptake in hot spots, outside hotspots, and in infiltrating tumor edges unanimously reflects tumor cell density. The correlation between MET uptake and vessel density and density of proliferating cells is less stringent in infiltrating tumor edges and is probably more susceptible to artifacts caused by larger blood vessels surrounding the tumor. Although based on a limited number of samples, this study provides histological proof for MET as an indicator of tumor cell density and for the lack of statistically significant correlations between rCBV and histological cell markers in oligodendrogliomas.

Identifiants

pubmed: 30109401
doi: 10.1007/s00259-018-4107-z
pii: 10.1007/s00259-018-4107-z
pmc: PMC6351509
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-579

Références

J Nucl Med. 2000 Jul;41(7):1250-5
pubmed: 10914918
Radiother Oncol. 2000 Aug;56(2):151-6
pubmed: 10927133
Neuro Oncol. 2001 Jul;3(3):193-200
pubmed: 11465400
Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82
pubmed: 11926379
Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):868-73
pubmed: 12692687
Brain. 2005 Mar;128(Pt 3):678-87
pubmed: 15689365
Brain Pathol. 2005 Oct;15(4):297-310
pubmed: 16389942
J Neurosurg. 2006 Feb;104(2):238-53
pubmed: 16509498
Brain. 2006 Jul;129(Pt 7):1884-91
pubmed: 16670176
Genome Biol. 2006;7(10):R100
pubmed: 17076895
J Clin Oncol. 2006 Dec 1;24(34):5419-26
pubmed: 17135643
Arch Pathol Lab Med. 2007 Mar;131(3):397-406
pubmed: 17516742
Lancet Neurol. 2007 Aug;6(8):711-24
pubmed: 17638612
AJNR Am J Neuroradiol. 2008 Mar;29(3):476-82
pubmed: 18079184
J Neurooncol. 2009 Jan;91(2):213-20
pubmed: 18807224
J Neuroradiol. 2010 May;37(2):89-97
pubmed: 19570578
Neuroimage. 2010 Feb 15;49(4):2977-82
pubmed: 19931401
Lancet Neurol. 2010 Sep;9(9):906-20
pubmed: 20705518
Eur J Neurol. 2010 Sep;17(9):1124-33
pubmed: 20718851
AJNR Am J Neuroradiol. 2011 Mar;32(3):501-6
pubmed: 21163880
Stroke. 2011 Jul;42(7):2054-60
pubmed: 21636816
Cancer. 2012 Mar 15;118(6):1619-27
pubmed: 21837671
AJNR Am J Neuroradiol. 2012 Jan;33(1):69-76
pubmed: 22095961
Br J Radiol. 2012 Dec;85(1020):e1204-11
pubmed: 23175486
Neuro Oncol. 2013 Oct;15(10):1379-88
pubmed: 23771168
J Neurooncol. 2013 Sep;114(2):241-9
pubmed: 23771511
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Neuroradiology. 2014 Dec;56(12):1031-8
pubmed: 25204450
Eur J Nucl Med Mol Imaging. 2015 May;42(6):905-15
pubmed: 25750084
Acta Neuropathol. 2015 Jun;129(6):809-27
pubmed: 25943885
Ann Nucl Med. 2016 Feb;30(2):89-96
pubmed: 26511019
Acta Radiol. 1989 May-Jun;30(3):225-32
pubmed: 2660886
Onco Targets Ther. 2015 Dec 17;8:3803-15
pubmed: 26719708
Br J Radiol. 2016;89(1060):20150857
pubmed: 26849038
World Neurosurg. 2016 May;89:230-9
pubmed: 26855307
J Neurosurg. 2016 Nov;125(5):1155-1166
pubmed: 26918468
J Neurosurg. 2016 Nov;125(5):1136-1142
pubmed: 26918477
N Engl J Med. 2016 Apr 7;374(14):1344-55
pubmed: 27050206
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
J Neurosurg. 2018 Apr;128(4):1076-1083
pubmed: 28498059
Methods. 2017 Nov 1;130:124-134
pubmed: 28552264
Clin Transl Imaging. 2017;5(3):209-223
pubmed: 28680873
J Immunol. 1984 Oct;133(4):1710-5
pubmed: 6206131
Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):768-72
pubmed: 7531342
Med Phys. 1997 Jan;24(1):25-35
pubmed: 9029539
Neuropathol Appl Neurobiol. 1998 Feb;24(1):21-8
pubmed: 9549725
Am J Surg Pathol. 1998 Jul;22(7):816-26
pubmed: 9669344

Auteurs

Kenney Roy Roodakker (KR)

Department of Neuroscience, Neurology, Uppsala University, University Hospital, S-751 85, Uppsala, Sweden. kenney.roodakker@neuro.uu.se.

Ali Alhuseinalkhudhur (A)

Department of Neuroscience, Neurology, Uppsala University, University Hospital, S-751 85, Uppsala, Sweden.
Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.

Mohammed Al-Jaff (M)

Department of Information Technology, Division of Visual Information and Interaction, Uppsala University, Uppsala, Sweden.

Maria Georganaki (M)

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

Maria Zetterling (M)

Department of Neuroscience, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.

Shala G Berntsson (SG)

Department of Neuroscience, Neurology, Uppsala University, University Hospital, S-751 85, Uppsala, Sweden.

Torsten Danfors (T)

Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.

Robin Strand (R)

Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Department of Information Technology, Division of Visual Information and Interaction, Uppsala University, Uppsala, Sweden.

Per-Henrik Edqvist (PH)

Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Anna Dimberg (A)

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

Elna-Marie Larsson (EM)

Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Department of Radiology, Uppsala University Hospital, Uppsala, Sweden.

Anja Smits (A)

Department of Neuroscience, Neurology, Uppsala University, University Hospital, S-751 85, Uppsala, Sweden.
Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH